Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/58409
Campo DC | Valor | idioma |
---|---|---|
dc.contributor.author | Saavedra Díaz, Ester Gloria | en_US |
dc.contributor.author | Del Rosario, Henoc | en_US |
dc.contributor.author | Brouard, Ignacio | en_US |
dc.contributor.author | Hernández-Garcés, Judith | en_US |
dc.contributor.author | García, Celina | en_US |
dc.contributor.author | Quintana, José | en_US |
dc.contributor.author | Estévez, Francisco | en_US |
dc.date.accessioned | 2019-12-15T18:10:57Z | - |
dc.date.available | 2019-12-15T18:10:57Z | - |
dc.date.issued | 2019 | en_US |
dc.identifier.issn | 0045-2068 | en_US |
dc.identifier.other | Scopus | - |
dc.identifier.other | WoS | - |
dc.identifier.uri | http://hdl.handle.net/10553/58409 | - |
dc.description.abstract | Synthetic flavonoids containing a naphthalene ring have attracted attention as potential cytotoxic compounds. Here, we synthesized ten chalcones and their corresponding flavanones and evaluated their antiproliferative activity against the human tumour cell line U-937. This series of chalcone derivatives was characterized by the presence of a naphthalene ring which was kept unaltered- and attached to the β carbon of the 1-phenyl-2-propen-1-one framework. The structure-activity relationship of these chalcone derivatives and their corresponding cyclic compounds was investigated by the introduction of different substituents (methyl, methoxy, benzyloxy, chlorine) or by varying the position of the methoxy or benzyloxy groups on the A ring. The results revealed that both the chalcone containing the methoxy group at 5′ position of the A ring as well as its corresponding flavanone [6-methoxy-2-(naphthalen-1-yl)chroman-4-one] were the most cytotoxic compounds, with IC50 values of 2.8 ± 0.2 and 1.3 ± 0.2 μM, respectively, against U-937 cells. This synthetic flavanone was as cytotoxic as the antitumor etoposide in U-937 cells and displayed strong cytotoxicity against additional human leukaemia cell lines, including HL-60, MOLT-3 and NALM-6. Human peripheral blood mononuclear cells were more resistant than leukaemia cells to the cytotoxic effects of the flavanone. Treatment of U-937 cells with this compound induced G2-M cell cycle arrest, an increase in sub-G1 ratio and annexin-V positive cells, mitochondrial cytochrome c release, caspase activation and poly(ADP-ribose)polymerase processing. Apoptosis induction triggered by this flavonoid was blocked by overexpression of the anti-apoptotic protein Bcl-2. This flavanone induces phosphorylation of p38 mitogen-activated protein kinases, extracellular-signal regulated kinases and c-jun N-terminal kinases/stress-activated protein kinases (JNK/SAPK) following different kinetics. Moreover, cell death was attenuated by the inhibition of mitogen-activated extracellular kinases and JNK/SAPK and was independent of reactive oxygen species generation. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Bioorganic Chemistry | en_US |
dc.source | Bioorganic Chemistry [ISSN 0045-2068], v. 94, (Enero 2020) | en_US |
dc.subject | 2403 Bioquímica | en_US |
dc.subject | 2415 Biología molecular | en_US |
dc.subject.other | Apoptosis | en_US |
dc.subject.other | Structure-activity relationship | en_US |
dc.subject.other | Caspase | en_US |
dc.subject.other | Cell cycle | en_US |
dc.subject.other | Cytotoxicity | en_US |
dc.subject.other | Flavanone | en_US |
dc.title | The synthetic flavanone 6-methoxy-2-(naphthalen-1-yl)chroman-4-one induces apoptosis and activation of the MAPK pathway in human U-937 leukaemia cells | en_US |
dc.type | info:eu-repo/semantics/article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1016/j.bioorg.2019.103450 | en_US |
dc.identifier.scopus | 85075825587 | - |
dc.identifier.isi | 000505596300101 | - |
dc.contributor.authorscopusid | 57190224633 | - |
dc.contributor.authorscopusid | 57190227049 | - |
dc.contributor.authorscopusid | 6603470039 | - |
dc.contributor.authorscopusid | 57212061177 | - |
dc.contributor.authorscopusid | 7401486069 | - |
dc.contributor.authorscopusid | 8681043500 | - |
dc.contributor.authorscopusid | 7003810011 | - |
dc.identifier.eissn | 1090-2120 | - |
dc.identifier.issue | 103450 | - |
dc.relation.volume | 94 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.contributor.daisngid | 10748553 | - |
dc.contributor.daisngid | 13640797 | - |
dc.contributor.daisngid | 657275 | - |
dc.contributor.daisngid | 31852447 | - |
dc.contributor.daisngid | 31425573 | - |
dc.contributor.daisngid | 128315 | - |
dc.contributor.daisngid | 31460012 | - |
dc.description.numberofpages | 14 | en_US |
dc.utils.revision | Sí | en_US |
dc.contributor.wosstandard | WOS:Saavedra, E | - |
dc.contributor.wosstandard | WOS:Del Rosario, H | - |
dc.contributor.wosstandard | WOS:Brouard, I | - |
dc.contributor.wosstandard | WOS:Hernandez-Garces, J | - |
dc.contributor.wosstandard | WOS:Garcia, C | - |
dc.contributor.wosstandard | WOS:Quintana, J | - |
dc.contributor.wosstandard | WOS:Estevez, F | - |
dc.date.coverdate | Enero 2020 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.sjr | 0,819 | |
dc.description.jcr | 4,831 | |
dc.description.sjrq | Q1 | |
dc.description.jcrq | Q1 | |
dc.description.scie | SCIE | |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Bioquímica | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | GIR IUIBS: Bioquímica | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología | - |
crisitem.author.dept | GIR IUIBS: Bioquímica | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología | - |
crisitem.author.dept | GIR IUIBS: Bioquímica | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología | - |
crisitem.author.orcid | 0000-0002-1717-386X | - |
crisitem.author.orcid | 0000-0001-8225-4538 | - |
crisitem.author.orcid | 0000-0002-9728-2774 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Saavedra Díaz, Ester Gloria | - |
crisitem.author.fullName | Del Rosario García, Henoc | - |
crisitem.author.fullName | Quintana Aguiar, José Martín | - |
crisitem.author.fullName | Estévez Rosas, Francisco Jesús | - |
Colección: | Artículos |
Citas SCOPUSTM
6
actualizado el 10-nov-2024
Citas de WEB OF SCIENCETM
Citations
4
actualizado el 23-may-2024
Visitas
117
actualizado el 09-mar-2024
Google ScholarTM
Verifica
Altmetric
Comparte
Exporta metadatos
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.